Oncolytics Biotech
ONCY
#9623
Rank
S$0.13 B
Marketcap
S$1.10
Share price
2.50%
Change (1 day)
-27.95%
Change (1 year)

Oncolytics Biotech (ONCY) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$17.15 Million

According to Oncolytics Biotech 's latest financial reports the company's total liabilities are S$17.15 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oncolytics Biotech - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$14.61 M6.19%
2024-12-31S$13.75 M22.78%
2023-12-31S$11.2 M4.74%
2022-12-31S$10.69 M3.17%
2021-12-31S$10.37 M4.21%
2020-12-31S$9.95 M-51.22%
2019-12-31S$20.39 M134.59%
2018-12-31S$8.69 M-17.13%
2017-12-31S$10.49 M139.54%
2016-12-31S$4.38 M58.62%
2015-12-31S$2.76 M-28.08%
2014-12-31S$3.84 M-46.29%
2013-12-31S$7.14 M-20.23%
2012-12-31S$8.96 M8.64%
2011-12-31S$8.25 M156.16%
2010-12-31S$3.22 M-43.17%
2009-12-31S$5.66 M6.37%
2008-12-31S$5.32 M29.97%
2007-12-31S$4.09 M12.64%
2006-12-31S$3.63 M37.78%
2005-12-31S$2.64 M77.06%
2004-12-31S$1.49 M10.02%
2003-12-31S$1.35 M-12.76%
2002-12-31S$1.55 M-57.14%
2001-12-31S$3.62 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eli Lilly
LLY
S$110.21 B 642,274.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$85.67 B 499,290.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
S$0.23 B 1,278.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
S$30.74 M 79.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$41.05 B 239,219.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
S$93.44 M 444.64%๐Ÿ‡บ๐Ÿ‡ธ USA